This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / MindMaze Therapeutics 2026 AGM Invitation
Business Annual General Meeting

MindMaze Therapeutics 2026 AGM Invitation

Analysis based on 8 articles · First reported Jun 03, 2026 · Last updated Jun 03, 2026

Sentiment
10
Attention
2
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The announcement of the Annual General Meeting by Coeptis Therapeutics Holdings provides transparency to investors regarding upcoming governance and financial decisions. The proposed election of new board members and the potential increase in conditional share capital could influence investor confidence and the future valuation of Coeptis Therapeutics Holdings.

Biotechnology Healthcare
Event Summary

Coeptis Therapeutics Holdings has published the invitation to its 2026 Annual General Meeting (AGM), scheduled for June 25, 2026, in Switzerland — Geneva, Switzerland. Key proposals on the agenda include the re-election of current Board members and the election of Brad Hollinger (Founder, Chairman, and CEO of Vibra Healthcare) and Rose Henderson (CEO of Coeptis Therapeutics Holdings) as new Board members. Shareholders will also vote on the approval of the 2025 Annual Report and financial statements, the election of members for the Nomination and Compensation Committee, the Independent Proxy, and statutory auditors. Additionally, votes on the compensation of the Board of Directors and the Executive Committee, and an increase in the company's conditional share capital are planned. These decisions are crucial for the future governance and financial direction of Coeptis Therapeutics Holdings.

Entities Involved
stock
Coeptis Therapeutics Holdings
Coeptis Therapeutics Holdings is holding its 2026 Annual General Meeting to discuss key proposals including board elections, financial statements, and an increase in conditional share capital. These decisions will directly affect the company's governance and financial structure.
Importance 100.0 Sentiment 10.0
per
Brad Hollinger
Brad Hollinger is proposed for election as a new member of the Board of Directors of Coeptis Therapeutics Holdings, which could bring new leadership and strategic direction to the company.
Importance 70.0 Sentiment 5.0
per
Rose Henderson
Rose Henderson, the current CEO of Coeptis Therapeutics Holdings, is proposed for election as a new member of the Board of Directors, indicating a potential strengthening of his influence within the company's governance.
Importance 70.0 Sentiment 5.0
priv
Vibra Healthcare
Vibra Healthcare is mentioned as the company where Brad Hollinger serves as Founder, Chairman, and CEO, providing context for his professional background.
Importance 20.0 Sentiment 0.0
loc
Switzerland — Geneva
Switzerland — Geneva is the specific city in Switzerland where Coeptis Therapeutics Holdings will hold its 2026 Annual General Meeting.
Importance 10.0 Sentiment 0.0
cnt
Switzerland
Switzerland is the host country for the 2026 Annual General Meeting of Coeptis Therapeutics Holdings, specifically in Switzerland — Geneva.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.